Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 13, 2014

Primary Completion Date

March 3, 2018

Study Completion Date

December 31, 2018

Conditions
Malignant NeoplasmSolid Tumors
Interventions
DRUG

Chloroquine

Dose is 50, 100, 150, and 200 mg per day cohorts. It is given one week prior to the initiation of chemotherapy and then given for four 21 day cycles in combination with chemotherapy.

DRUG

Carboplatin

Administered day 1 of each 21 day cycle for 4-6 cycles.

DRUG

Gemcitabine

Administered days 1 and 8 of each 21 day cycle for 4-6 cycles.

Trial Locations (1)

45267-0502

University of Cincinnati Cancer Institute, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT02071537 - Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter